Food and Drug Administration's Compact Regs Parts 50, 54, 56, and 312: CFR 21 Parts 50, 56, PDF

By Food and Drug Administration

ISBN-10: 0849321883

ISBN-13: 9780849321887

Show description

Read or Download Compact Regs Parts 50, 54, 56, and 312: CFR 21 Parts 50, 56, and 312 Good Clinical Practices (10 Pack) PDF

Similar biomedical engineering books

Hanry Yu, Pao-Chun Lin, Fu-Jen Kao's Multi-Modality Microscopy PDF

This publication covers very important points of contemporary optical microscopy and snapshot recovery applied sciences. rather than natural optical remedy, the booklet is introduced with the respect of the scientists who make the most of optical microscopy of their day-by-day learn. despite the fact that, sufficient info are supplied in easy imaging rules, optics and instrumentation in microscopy, round aberrations, deconvolution and photograph recovery.

Principles of Tissue Engineering by Robert Lanza PDF

First released in 1997, ideas of Tissue Engineering is the generally famous definitive source within the box. The 3rd variation offers a miles wanted replace of the fast growth that has been completed within the box, combining the must haves for a common figuring out of tissue development and improvement, the instruments and theoretical info had to layout tissues and organs, in addition to a presentation through the world's specialists of what's presently identified approximately every one particular organ process.

4th International Workshop on Wearable and Implantable Body - download pdf or read online

This publication includes papers from the overseas Workshop on Wearable and Implantable physique Sensor Networks, BSN 2007, held in March 2007 on the college health facility Aachen, Germany. themes coated within the quantity comprise new clinical measurements, shrewdpermanent bio-sensing textiles, low-power instant networking, method integration, scientific sign processing, multi-sensor info fusion, and on-going standardization actions.

Download e-book for iPad: Chemo-Mechanical Couplings in Porous Media Geomechanics and by Benjamin Loret, Jacques M. Huyghe

The publication addresses basic concerns confronted by way of experimentalists, modelers and engineers attracted to diversified actual, mechanical and delivery facets of organic tissues and chemically energetic geological fabrics, generally clays and shales. the point of interest is at the couplings among electro-chemical and mechanical points interested by swelling and chemical consolidation.

Additional info for Compact Regs Parts 50, 54, 56, and 312: CFR 21 Parts 50, 56, and 312 Good Clinical Practices (10 Pack)

Sample text

As drug development proceeds, the sponsor is required to submit informational amendments, as appropriate, with additional information pertinent to safety. (i) Pharmacology and drug disposition. A section describing the pharmacological effects and mechanism(s) of action of the drug in animals, and information on the absorption, distribution, metabolism, and excretion of the drug, if known. (ii) Toxicology. (a) An integrated summary of the toxicological effects of the drug in animals and in vitro.

B) The records required by this regulation shall be retained for at least 3 years after completion of the research, and the records shall be accessible for inspection and copying by authorized representatives of the Food and Drug Administration at reasonable times and in a reasonable manner. (c) The Food and Drug Administration may refuse to consider a clinical investigation in support of an application for a research or marketing permit if the institution or the IRB that reviewed the investigation refuses to allow an inspection under this section.

Modifications of the experimental design of Phase 1 studies that do not affect critical safety assessments are required to be reported to FDA only in the annual report. (ii) In Phases 2 and 3, detailed protocols describing all aspects of the study should be submitted. A protocol for a Phase 2 or 3 investigation should be designed in such a way that, if the sponsor anticipates that some deviation from the study design may become necessary as the investigation progresses, alternatives or contingencies to provide for such deviation are built into the protocols at the outset.

Download PDF sample

Compact Regs Parts 50, 54, 56, and 312: CFR 21 Parts 50, 56, and 312 Good Clinical Practices (10 Pack) by Food and Drug Administration

by John

Rated 4.81 of 5 – based on 5 votes